Kinder Morgan Inc vs Sana Biotechnology Inc — how do they compare? Kinder Morgan Inc trades at $32.47 (market cap $72.48B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Kinder Morgan Inc is far larger — about 82.9× Sana Biotechnology Inc's market cap, and Kinder Morgan Inc pays a 3.61% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| KMI | SANA | |
|---|---|---|
Market Cap | $72.48B | $873.84M |
Sector | Energy | Health |
52-Week High | $34.31 | $5.92 |
52-Week Low | $25.84 | $2.68 |
Enterprise Value | $104.36B | $848.03M |
Dividend Yield | 3.61% | — |
Trailing returns across standard periods
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →